LAUSR

Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting

Sign Up to like & get
recommendations!
1 Published in 2020 at "Clinical Pharmacology and Therapeutics"

DOI: 10.1002/cpt.2074

Abstract: We improved a previous pharmacological target adverse‐event (TAE) profile model to predict adverse events (AEs) on US Food and Drug Administration (FDA) drug labels at the time of approval. The new model uses more drugs… read more here.

Keywords: event; adverse event; drug labels; target adverse ... See more keywords